ASPIRIN DELAYED-RELEASE TABLETS. Key specifications include administration: ORAL, special_features: W/CHILD RESISTANT CLOSURE, primary_container_type: BOTTLE, medical_designation_and_grade: UNITED STATES PHARMACOPEIA, primary_container_content_quantity: 36.000 TABLETS, active_medicament_medicinal_strength: 0.325 GRAMS ASPIRIN ACTIVE INGREDIENT G. This part is cataloged in the Federal Logistics Information System (FLIS) under NSN 6505-01-016-2224, indicating validated use in U.S.
government and defense logistics supply chains. Available through authorized enterprise resellers and TPM (Third Party Maintenance) channels. Verify compatibility with your specific system configuration before ordering.
| administration | ORAL |
| special_features | W/CHILD RESISTANT CLOSURE |
| primary_container_type | BOTTLE |
| medical_designation_and_grade | UNITED STATES PHARMACOPEIA |
| primary_container_content_quantity | 36.000 TABLETS |
| active_medicament_medicinal_strength | 0.325 GRAMS ASPIRIN ACTIVE INGREDIENT G |
| part_name_assigned_by_controlling_agency | ASPIRIN TABLETS USP 0.325GM 36S BT |
| NSN | 6505-01-016-2224 |
| SPECIAL FEATURES | W/CHILD RESISTANT CLOSURE |
| ACTIVE MEDICAMENT MEDICINAL STRENGTH | 0.325 GRAMS ASPIRIN ACTIVE INGREDIENT G |
| MEDICAL DESIGNATION AND GRADE | UNITED STATES PHARMACOPEIA |
| PRIMARY CONTAINER TYPE | BOTTLE |
| PART NAME ASSIGNED BY CONTROLLING AGENCY | ASPIRIN TABLETS USP 0.325GM 36S BT |
| PRIMARY CONTAINER CONTENT QUANTITY | 36.000 TABLETS |
| ADMINISTRATION | ORAL |